News | February 07, 2022
India grants Emergency Use Authorisation to Sputnik Light
This is the ninth Covid-19 vaccine approved in India
This is the ninth Covid-19 vaccine approved in India
The antimicrobial resistance alliance recently released its third Progress Report, reflecting on collective achievements from the life sciences industry
Pfizer and Moderna are also working on vaccines that target the Omicron variant
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
Corbevax is administered through an intramuscular route with two doses scheduled 28 days apart and is stored between 2 degrees celsius to 8 degrees celsius
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
It has a total of 50 ANDA approvals from USFDA
The vaccine will be priced at Rs. 265 per dose and the applicator being offered at Rs. 93 per dose excluding GST
The tablets are indicated for the treatment of overactive bladder (OAB) in adults with symptoms of urge urinary incontinence, urgency, and frequency
Spikevax has received approval by regulators in more than 70 countries, including Canada, Japan, the European Union, the UK, Israel
Subscribe To Our Newsletter & Stay Updated
